These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15021865)

  • 1. Divalproex in the treatment of migraine.
    Freitag FG
    Psychopharmacol Bull; 2003; 37 Suppl 2():98-115. PubMed ID: 15021865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability.
    D'Amico D
    Neurol Sci; 2007 May; 28 Suppl 2():S188-97. PubMed ID: 17508169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravenous valproic acid for acute migraine.
    Frazee LA; Foraker KC
    Ann Pharmacother; 2008 Mar; 42(3):403-7. PubMed ID: 18303140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM; Mueller LL; Freitag FG
    J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of migrainous features in cluster headache: divalproex responsiveness.
    Wheeler SD
    Headache; 1998; 38(7):547-51. PubMed ID: 15613172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
    Linde M; Mulleners WM; Chronicle EP; McCrory DC
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010611. PubMed ID: 23797677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
    Stillman MJ; Zajac D; Rybicki LA
    Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and mechanism of anticonvulsant drugs in migraine.
    Hoffmann J; Akerman S; Goadsby PJ
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):191-201. PubMed ID: 24494792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials.
    Smith MC; Centorrino F; Welge JA; Collins MA
    Epilepsy Behav; 2004 Oct; 5(5):746-51. PubMed ID: 15380129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divalproex sodium in the treatment of adults with bipolar disorder.
    Davis LL; Williams R; Cates M
    Expert Rev Neurother; 2004 May; 4(3):349-62. PubMed ID: 15853533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate semisodium ER for migraine and cluster headache prophylaxis.
    Lovell BV; Marmura MJ
    Expert Opin Drug Metab Toxicol; 2010 Apr; 6(4):495-504. PubMed ID: 20298131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM; Schim JD; Chippendale TJ
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
    Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
    Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine.
    Reiter PD; Nickisch J; Merritt G
    Headache; 2005; 45(7):899-903. PubMed ID: 15985107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight change associated with the use of migraine-preventive medications.
    Taylor FR
    Clin Ther; 2008 Jun; 30(6):1069-80. PubMed ID: 18640463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid in migraine prophylaxis of young patients. Three new reports.
    Fusco C; Pisani F; Capone C; Faienza C
    Acta Biomed; 2002; 73(3-4):47-51. PubMed ID: 12596387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G; Marková J; Mastík J
    Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divalproex sodium in headache: literature review and clinical guidelines.
    Silberstein SD
    Headache; 1996 Oct; 36(9):547-55. PubMed ID: 8916563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divalproex sodium extended-release for the prophylaxis of migraine headache.
    Freitag FG
    Expert Opin Pharmacother; 2003 Sep; 4(9):1573-8. PubMed ID: 12943487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.